Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. DBV Technologies
  6. News
  7. Summary
    DBV   FR0010417345

DBV TECHNOLOGIES

(DBV)
  Report
Real-time Euronext Paris  -  11:35:20 2023-02-03 am EST
2.660 EUR   -1.04%
02/01Telecoms, Natural Resources Lead European Equities Lower in Wednesday Trading
MT
01/27European Equities Move Lower Friday, Set to End Week in Negative Territory
MT
01/23Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about DBV TECHNOLOGIES
01/23Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GL
01/23Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AQ
2022European Equities Rise Modestly in Friday Trading, End Week Up 1%
MT
2022Sector Update: Health Care Stocks Mixed Premarket Friday
MT
2022Sector Update: Health Care
MT
2022DBV Technologies Says FDA Lifts Partial Clinical Hold on Clinical Trial of Therapy For ..
MT
2022US FDA Lifts Partial Clinical Hold on DBV Technologies Trial for Peanut Allergy Patch i..
MT
2022DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivo..
GL
2022DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivo..
AQ
2022DBV Technologies Announces FDA Lifts Partial Clinical Hold on VITESSE Phase 3 Pivotal T..
CI
2022Peanut Allergy Pipeline as Novel and Extensive 15+ Therapies Likely to Enter in the Tre..
AQ
2022DBV Technologies to Participate in Upcoming Investor Conference
GL
2022DBV Technologies to Participate in Upcoming Investor Conference
AQ
2022DBV Technologies to Highlight New Clinical Data at ACAAI 2022
GL
2022DBV Technologies to Highlight New Clinical Data at ACAAI 2022
AQ
More most relevant news
All news about DBV TECHNOLOGIES
02/01Telecoms, Natural Resources Lead European Equities Lower in Wednesday Trading
MT
01/27European Equities Move Lower Friday, Set to End Week in Negative Territory
MT
01/23Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GL
01/23Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AQ
01/23European Equities Rise as Consumer Confidence Grows
MT
01/18Tech Stocks Lead European Equities Modestly Higher in Wednesday Trading
MT
01/13European Equities Rise in Friday Trading, ADRs End Week Up 2%
MT
01/12European Equities Led Higher by Financial, Telecoms Stocks
MT
01/11Pharma Stocks Pull European Equities Lower in Wednesday Trading
MT
01/05Pharma Stocks Lead European Equities Lower in Thursday Trading
MT
More news
News in other languages on DBV TECHNOLOGIES
02/01Les télécoms et les ressources naturelles entraînent les actions européennes à la baiss..
01/27Les actions européennes baissent vendredi et devraient terminer la semaine en territoir..
01/27Dbv Technologies : Document AMF CP. 223C0192
01/26Dbv Technologies : Document AMF CP. 223C0183
01/23Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
01/23Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
01/23Les actions européennes progressent en raison de la hausse de la confiance des consomma..
01/18Les valeurs technologiques mènent les actions européennes en légère hausse dans les éch..
01/13Les actions européennes progressent vendredi, les ADRs terminent la semaine en hausse d..
01/12Les actions européennes portées à la hausse par les valeurs financières et les télécoms
More news
Analyst Recommendations on DBV TECHNOLOGIES
2022Kepler Cheuvreux Upgrades DBV Technologies to Buy From Hold
MT
2022Goldman Sachs Downgrades DBV Technologies to Neutral From Buy
MT
2021JMP Securities Adjusts Price Target on DBV Technologies to $5 From $8, Maintains Market..
MT
2021HC Wainwright Adjusts DBV Technologies' Price Target to $10 From $14, Keeps Buy Rating
MT
2021DBV Technologies S A : Societe Generale Upgrades DBV Technologies t..
MT
More recommendations
Press releases
01/23Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GL
01/23Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AQ
2022Dbv Technologies S.a. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2022DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivo..
GL
2022DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivo..
AQ
More press releases
Upcoming event on DBV TECHNOLOGIES
03/08/23FY 2022 Earnings Release (Projected)
Upcoming sector events
02/07/23SK BIOPHARMACEUTICALS CO., LTD. : FY 2022 Earnings Release (Projected)
02/07/23KYOWA KIRIN CO., LTD. : FY 2022 Earnings Release
03/02/23MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN : FY 2022 Earnings Release
04/18/23ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD : FY 2022 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Specialty & Advanced Pharmaceuticals